Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to American Journal of Obstetrics & Gynecology
- Neonatal abstinence syndrome an associated health care expenditures United States, 2000-2009.JAMA. 2012; 307: 1934-1940
- Prescription opioid epidemic and infant outcomes.Pediatrics. 2015; 135: 842-850
- Treatment Episode Data Set (TEDS): 2000-2010. National Admissions to Substance Abuse Treatment Services. DASIS Series S-61, HHS Publication No. (SMA) 12-4701.Substance Abuse and Mental Health Services Administration, Rockville (MD)2012
- Incidence of neonatal abstinence syndrome – 28 states, 1999-2013.MMWR Morb Mortal Wkly Rep. 2016; 65: 799-802
- Factors associated with buprenorphine versus methadone use in pregnancy.Subst Abus. 2016; 37: 550-557
- Guidelines for the identification and management of substance use and substance use disorders in pregnancy.World Health Organization, Geneva, Switzerland2014
American Society of Addiction Medicine (ASAM). The ASAM National Practice Guidelines for the use of medications in the treatment of addiction involving opioid use. Available at: http://www.asam.org/docs/default-source/practice-support/guidelines-and-consensus-docs/asam-national-practice-guideline-supplement.pdf. Accessed March 10, 2017.
- Neonatal abstinence syndrome after methadone or buprenorphine exposure.N Engl J Med. 2010; 363: 2320-2331
- Prenatal antecedents of newborn neurological maturation.Child Dev. 2010; 81: 115-130
- Fetal neurobehavioral effects of exposure to methadone or buprenorphine.Neurotoxicol Teratol. 2011; 33: 240-243
- Fetal assessment before or after dosing with buprenorphine or methadone.Addiction. 2012; 107: 36-44
- Pregnancy and Addiction: A Comprehensive Care Model.J Subst Abuse Treat. 1996; 13: 321-329
- Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrument.Drug Alcohol Depend. 2009; 105: 154-159
- Doppler recordings of fetal movement: clinical correlation with real-time ultrasound.Obstet Gynecol. 1989; 74: 277-280
- Development of fetal movement-fetal heart rate coupling from 20 weeks through term.Early Hum Dev. 1996; 44: 139-151
- Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy.BJOG. 1999; 106: 498-500
- Intra-hepatic cholestasis of pregnancy in hepatitis C virus infection.Acta Obstet Gynecol Scand. 2002; 81: 99-103
- Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population based study.Hepatology. 2006; 43: 723-728
- Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis.Clin Res Hepatol Gastroenterol. 2017; 41: 39-45
- Fetal response to maternal methadone administration.Obstet Gynecol. 2005; 193: 611-617
- Studies in fetal behavior: revisited, renewed and reimagined.Monogr Soc Res Child Dev. 2015; 80: 1-94
- Maternal buprenorphine maintenance and lactation.J Hum Lact. 2016; 32: 675-681
- Methadone maintenance and breastfeeding in the neonatal period.Pediatrics. 2008; 121: 106-114
- Effects of smoking and fetal hypokinesia in early pregnancy.Arch Med Res. 2007; 38: 864-867
- Smoking in pregnancy: effects on mother and fetus.BJOG. 1984; 91: 111-117
Dr King is now affiliated with the Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas.
Supported by National Institutes of Health/National Institute of Drug Abuse RO1 DA013689 . Study medication was provided by Indivior, who had no role in study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the manuscript for publication.
Dr Jansson was a paid consultant for Chiesi, Inc.
Clinical Trials Registry name and registration number: Fetal and Infant Effects of Maternal Buprenorphine Treatment NCT15671079 https://clinicaltrials.gov/ct2/show/NCT01561079?term=jansson&rank=12.
Cite this article as: Jansson LM, Velez M, McConnell K, et al. Maternal buprenorphine treatment and fetal neurobehavioral development. Am J Obstet Gynecol 2017;216:529.e1-8.